Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
dTub
Скачать

The Urgency to Approve Govorestat For the Treatment of Galactosemia

galactosemia

dairy free diet

neurodegenerative disorder

failure to thrive

fda

biotech

biopharma

clinical trial

primary endpoints

statistics

post hoc analysis

quality of life

Автор: CheckRare

Загружено: 30 мая 2023 г.

Просмотров: 519 просмотров

Описание:

Shoshana Shendelman, Ph.D., President and Chief Executive Officer of Applied Therapeutics, explains why it is important to find newer treatment options for persons with galactosemia.

Galactosemia is a rare, metabolic disorder that affects an individual's ability to metabolize galactose. This genetic abnormality involves mutations in the GALT gene that result in the deficiency of the GALT enzyme that breaks down galactose. The toxic metabolites that accumulate in the cells include galactose-1-phophate and galactitol. If left untreated, galactosemia can lead to serious complications such as cataracts, intellectual disability, speech difficulties, and neurological problems. The only treatment currently available is a very strict, dairy-free diet.

Govorestat is an aldose reductase inhibitor in development to treat galactosemia. Recently, a phase 3 clinical trial testing govorestat to treat galactosemia did not meet its primary endpoint but post hoc analysis did suggest the drug is very effective.

To learn more about galactosemia and other genetic conditions, visit checkrare.com/diseases/congenital-and-genetic-conditions/

The Urgency to Approve Govorestat  For the Treatment of Galactosemia

Поделиться в:

Доступные форматы для скачивания:

Скачать видео mp4

  • Информация по загрузке:

Скачать аудио mp3

Похожие видео

Efficacy of Govorestat to Treat Galactemia

Efficacy of Govorestat to Treat Galactemia

Galactosemia Expert Perspectives

Galactosemia Expert Perspectives

Govorestat for CMT-SORD: Designing a Clinical Trial for a Slow Progressing CMT

Govorestat for CMT-SORD: Designing a Clinical Trial for a Slow Progressing CMT

Cerebral Vascular Anatomy And Imaging

Cerebral Vascular Anatomy And Imaging

Respiratory Therapy - BiPAP vs. CPAP - How to adjust for ABGs?

Respiratory Therapy - BiPAP vs. CPAP - How to adjust for ABGs?

Addiction and Substance Use Disorder Mnemonics (Memorable Psychiatry Lecture)

Addiction and Substance Use Disorder Mnemonics (Memorable Psychiatry Lecture)

CAMP4 Therapeutics’ Programs For Urea Cycle Disorders and SYNGAP1

CAMP4 Therapeutics’ Programs For Urea Cycle Disorders and SYNGAP1

Arachidonic Acid Pathway (Prostaglandins, Prostacyclins, Thromboxanes, & Leukotrienes)

Arachidonic Acid Pathway (Prostaglandins, Prostacyclins, Thromboxanes, & Leukotrienes)

Galactosemia, Galactokinase deficiency, Lactose Intolerance - Lactose Metabolism Disorders - Biochem

Galactosemia, Galactokinase deficiency, Lactose Intolerance - Lactose Metabolism Disorders - Biochem

Cushing Syndrome - causes, symptoms, diagnosis, treatment, pathology

Cushing Syndrome - causes, symptoms, diagnosis, treatment, pathology

© 2025 dtub. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]